Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate.

Bak SP, Barnkob MS, Wittrup KD, Chen J.

Cancer Immunol Res. 2013 Dec;1(6):393-401. doi: 10.1158/2326-6066.CIR-13-0109. Epub 2013 Sep 20.

PMID:
24778132
[PubMed - in process]
Free PMC Article
2.

Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, Karrison T, Burnette B, Idel C, Zhao M, Hoffman RM, Munn DH, Rowley DA, Schreiber H.

Cancer Immunol Res. 2013 Aug;1(2):123-33. doi: 10.1158/2326-6066.CIR-13-0058.

PMID:
24455752
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.

Liu G, Lu S, Wang X, Page ST, Higano CS, Plymate SR, Greenberg NM, Sun S, Li Z, Wu JD.

J Clin Invest. 2013 Oct;123(10):4410-22. doi: 10.1172/JCI69369. Epub 2013 Sep 9.

PMID:
24018560
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Role of dendritic cells in the regulation of antitumor immunity.

Wathelet N, Moser M.

Oncoimmunology. 2013 Apr 1;2(4):e23973.

PMID:
23734333
[PubMed]
Free PMC Article
5.

Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization.

Xiao H, Peng Y, Hong Y, Huang L, Guo ZS, Bartlett DL, Fu N, Munn DH, Mellor A, He Y.

J Immunol. 2013 Jun 1;190(11):5866-73. doi: 10.4049/jimmunol.1203470. Epub 2013 Apr 22.

PMID:
23610140
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Sitkovsky M, Ohta A.

J Mol Med (Berl). 2013 Feb;91(2):147-55. doi: 10.1007/s00109-013-1001-9. Epub 2013 Jan 20. Review.

PMID:
23334369
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin.

Fiorenza S, Kenna TJ, Comerford I, McColl S, Steptoe RJ, Leggatt GR, Frazer IH.

J Immunol. 2012 Dec 15;189(12):5622-31. doi: 10.4049/jimmunol.1200709. Epub 2012 Nov 9.

PMID:
23144496
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer.

Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD.

J Immunol. 2012 Oct 15;189(8):3936-46. doi: 10.4049/jimmunol.1201415. Epub 2012 Sep 14.

PMID:
22984076
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.

Bak SP, Barnkob MS, Bai A, Higham EM, Wittrup KD, Chen J.

J Immunol. 2012 Aug 15;189(4):1708-16. doi: 10.4049/jimmunol.1201271. Epub 2012 Jul 13.

PMID:
22798683
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Stephan MT, Stephan SB, Bak P, Chen J, Irvine DJ.

Biomaterials. 2012 Aug;33(23):5776-87. doi: 10.1016/j.biomaterials.2012.04.029. Epub 2012 May 15.

PMID:
22594972
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Ohta A, Diwanji R, Kini R, Subramanian M, Ohta A, Sitkovsky M.

Front Immunol. 2011 Jul 5;2:27. doi: 10.3389/fimmu.2011.00027. eCollection 2011.

PMID:
22566817
[PubMed]
Free PMC Article
12.

Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.

Bruno TC, Rothwell C, Grosso JF, Getnet D, Yen HR, Durham NM, Netto G, Pardoll DM, Drake CG.

Prostate. 2012 Apr;72(5):514-22. doi: 10.1002/pros.21453. Epub 2011 Jul 14.

PMID:
21761425
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.

Donkor MK, Sarkar A, Savage PA, Franklin RA, Johnson LK, Jungbluth AA, Allison JP, Li MO.

Immunity. 2011 Jul 22;35(1):123-34. doi: 10.1016/j.immuni.2011.04.019. Epub 2011 Jul 14.

PMID:
21757379
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prostate cancer immunotherapy.

May KF Jr, Gulley JL, Drake CG, Dranoff G, Kantoff PW.

Clin Cancer Res. 2011 Aug 15;17(16):5233-8. doi: 10.1158/1078-0432.CCR-10-3402. Epub 2011 Jun 23.

PMID:
21700764
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent.

Olurinde MO, Shen CH, Drake A, Bai A, Chen J.

Cell Mol Immunol. 2011 Sep;8(5):415-23. doi: 10.1038/cmi.2011.18. Epub 2011 Jun 13.

PMID:
21666707
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.

DuPage M, Cheung AF, Mazumdar C, Winslow MM, Bronson R, Schmidt LM, Crowley D, Chen J, Jacks T.

Cancer Cell. 2011 Jan 18;19(1):72-85. doi: 10.1016/j.ccr.2010.11.011.

PMID:
21251614
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice.

Shir A, Ogris M, Roedl W, Wagner E, Levitzki A.

Clin Cancer Res. 2011 Mar 1;17(5):1033-43. doi: 10.1158/1078-0432.CCR-10-1140. Epub 2010 Dec 30.

PMID:
21196415
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.

Zhou Q, Xiao H, Liu Y, Peng Y, Hong Y, Yagita H, Chandler P, Munn DH, Mellor A, Fu N, He Y.

J Immunol. 2010 Nov 1;185(9):5082-92. doi: 10.4049/jimmunol.1001821. Epub 2010 Oct 6.

PMID:
20926790
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prostate cancer as a model for tumour immunotherapy.

Drake CG.

Nat Rev Immunol. 2010 Aug;10(8):580-93. doi: 10.1038/nri2817. Review.

PMID:
20651745
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing.

Ghosh SK, Kim P, Zhang XA, Yun SH, Moore A, Lippard SJ, Medarova Z.

Cancer Res. 2010 Aug 1;70(15):6119-27. doi: 10.1158/0008-5472.CAN-10-1008. Epub 2010 Jul 7.

PMID:
20610630
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk